<DOC>
	<DOCNO>NCT00917046</DOCNO>
	<brief_summary>This protocol describe randomize multicenter clinical trial design test hypothesis 12-week program high-intensity interval training ( HIIT ) yield large beneficial effect stable heart failure patient current practice , define either similar training program volume moderate continuous training ( MCT ) recommendation regular exercise moderate intensity individual choice ( RRE ) .</brief_summary>
	<brief_title>The SMARTEX Heart Failure Study</brief_title>
	<detailed_description>Evaluation criterion leave ventricular dimension function measure echocardiography , aerobic capacity measure peak oxygen uptake , quality life , level physical activity questionnaire . Assessments make train program one year follow-up . Safety HIIT assess incidence adverse effect train program . Clinical event record worsen heart failure require intensified drug therapy ( diuretic ) , ventricular arrhythmia , hospitalization due cardiovascular disease , all-cause mortality one year follow-up . The core study initiate endorsed European Association Cardiovascular Prevention Rehabilitation , Section Basic Translational Research , European Society Cardiology , allow sub-studies involve one participating center . Preliminary calculation suggest total number 200 patient randomize 1:1:1 three intervention group need detect large beneficial effect HIIT p-value 0.05 statistical power 0.90 ( primary endpoint reverse remodeling , assess comparison group change leave ventricular end-diastolic dimension baseline 12 week ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Congestive heart failure myocardial infarction dilate cardiomyopathy : LVEF &lt; 0.35 , NYHA class II III , Stable without sign worsen least 6 week , Minimum 3 month optimal medical treatment , Previous revascularisation CRT 6 month inclusion . Significant intercurrent illness last 6 week , Known severe ventricular arrhythmia functional prognostic significance unless protect ICD , Significant ischemia , Hemodynamic deterioration exerciseinduced arrhythmia baseline testing , Other heart disease limit exercise tolerance ( valve disease significant hemodynamic consequence , hypertrophic cardiomyopathy etc. , Comorbidity may significantly influence oneyear prognosis , Functional mental disability may limit exercise , Patients schedule heart transplant time inclusion , A habit regular vigorous exercise participation program exercise training le 6 month inclusion , participation another clinical trial , Patients COPD FEV1 50 % expect value exclude , Patients take oral corticosteroid exclude case .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>All-cause heart failure patient</keyword>
	<keyword>coronary artery disease etiology</keyword>
	<keyword>dilate cardiomyopathy etiology</keyword>
</DOC>